Low-dose Buprenorphine Initiation for Opioid Use Disorder
Part of paid clinical trials in The Bronx, New York.
- Sponsor
- Montefiore Medical Center
- Study ID
- NCT05450718
- Phase
- PHASE4
- Status
- Recruiting
Conditions
- Opioid Use Disorder
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- buprenorphine-naloxone — DRUGLow-dose initiation of buprenorphine-naloxone protocol
- buprenorphine-naloxone — DRUGStandard clinical guidelines for a two-day buprenorphine-naloxone initiation
Study Details
The purpose of this study is to test whether low-dose buprenorphine initiation for treatment of opioid use disorder is safe and effective.
Key Dates
- Start date
- Nov 11, 2024
- Status verified
- Sep 2025
- Primary completion
- Mar 17, 2027
- Completion
- Jun 30, 2027
Study Design
- Enrollment
- 70 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Low-dose initiationParticipants randomized to low-dose buprenorphine initiation will start low-dose buprenorphine-naloxone (bup-nx) according to an at-home, 8-day protocol (below). Participants in the low-dose buprenorphine initiation arm will be allowed to continue taking the full opioid agonist that they were taking at the time of enrollment until they reach a therapeutic dose of buprenorphine-naloxone. Day 1: 0.5 mg once; Day 2: 0.5 mg every 12 hours; Day 3: 1 mg every 12 hours; Day 4: 2 mg every 12 hours; Day 5: 3mg every 12 hours; Day 6: 4 mg every 12 hours; Day 7: 6 mg every 12 hours; Day 8: 8 mg every 12 hours
- Active Comparator: Treatment as usualParticipants randomized to treatment as usual will start buprenorphine-naloxone (bup-nx) following standard clinical guidelines for two-day, at-home initiation.
Primary Outcome Measure
Recruitment Feasibility: Percentage of subjects assessed who enroll in the clinical trial. [ Time Frame: At baseline study visit (time zero) ]
Central Contacts
- Benjamin T Hayes, MD, MS, MPH4156700850
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Montefiore Medical Center | The Bronx | New York | 10467 | Jessica Carter 718-920-5394 |
Find similar trials in The Bronx, NY
By research site
Related Studies
- IMPOWR-ME Project 1: Trial of Yoga and Physical Therapy Onsite at Opioid Treatment ProgramsRecruiting · Albert Einstein College of Medicine · The Bronx, New York
- Postpartum Intervention for Mothers With Opioid Use DisordersRecruiting · Stony Brook University · Ann Arbor, Michigan
- E-Cigarettes for Harm Reduction in Smokers With Opioid Use DisorderPHASE2 · Recruiting · NYU Langone Health · New York, New York
- Assessing Optimal XRB Initiation Points in JailPHASE4 · Recruiting · NYU Langone Health · Boston, Massachusetts